0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Diagnosis of Autoimmune Diseases - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: October 2024
|
Report Code: QYRE-Auto-36V5699
Home | Market Reports | Health| Health Conditions
Global Diagnosis of Autoimmune Diseases Market Insights Forecast to 2028
BUY CHAPTERS

Diagnosis of Autoimmune Diseases - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-36V5699
Report
October 2024
Pages:114
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Diagnosis of Autoimmune Diseases - Market Size

The global market for Diagnosis of Autoimmune Diseases was estimated to be worth US$ 1135 million in 2023 and is forecast to a readjusted size of US$ 1787 million by 2030 with a CAGR of 6.7% during the forecast period 2024-2030

Diagnosis of Autoimmune Diseases - Market

Diagnosis of Autoimmune Diseases - Market

The diagnosis of autoimmune diseases refers to the process of identifying and confirming the presence of an autoimmune condition in an individual. This process typically involves a comprehensive evaluation of the individual’s medical history, a physical examination, and various laboratory tests aimed at detecting specific antibodies, inflammation markers, and other indicators of an autoimmune response within the body. Additionally, imaging tests and, in some cases, tissue biopsies may be utilized to provide further insight into the presence and potential impact of the autoimmune disease on the affected organs or tissues.
Overall, the diagnosis of autoimmune diseases is a complex and often multidisciplinary endeavor that aims to accurately identify the specific autoimmune condition affecting an individual, thereby facilitating the development of an appropriate treatment plan and management strategy.
The global market for the diagnosis of autoimmune diseases encompasses a wide range of diagnostic technologies, tests, and tools used for identifying and monitoring various autoimmune conditions. This market includes but is not limited to laboratory-based tests such as blood tests, autoantibody assays, and biomarker analysis, as well as imaging techniques like MRI, CT scans, and ultrasound that are utilized in the diagnosis and monitoring of autoimmune diseases.
The market for autoimmune disease diagnosis is shaped by ongoing technological advancements, the development of innovative diagnostic tools, and an increasing focus on personalized and precision medicine approaches. Additionally, the growing prevalence of autoimmune diseases worldwide has contributed to the expansion of the diagnostic market.
The market is also influenced by the rising awareness about early diagnosis and treatment of autoimmune diseases, as well as the increasing efforts to improve the efficiency and accuracy of diagnostic tools. Furthermore, the integration of novel technologies such as artificial intelligence, molecular diagnostics, and point-of-care testing is likely to drive growth and innovation within the autoimmune disease diagnostics market.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Diagnosis of Autoimmune Diseases, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Diagnosis of Autoimmune Diseases by region & country, by Type, and by Application.
The Diagnosis of Autoimmune Diseases market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diagnosis of Autoimmune Diseases.
Market Segmentation

Scope of Diagnosis of Autoimmune Diseases - Market Report

Report Metric Details
Report Name Diagnosis of Autoimmune Diseases - Market
Forecasted market size in 2030 US$ 1787 million
CAGR 6.7%
Forecasted years 2024 - 2030
Segment by Type:
  • Routine Laboratory Tests
  • Inflammatory Markers
  • Autoantibodies & Immunologic Test
  • Other
Segment by Application
  • Rheumatoid Arthritis
  • Systemic Lupus Erythematosus
  • Sjögren’s Syndrome
  • Thyroiditis
  • Scleroderma
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Thermo Fisher Scientific, Siemens, Inova Diagnostics, GRIFOLS, Danaher, Bio-Rad Laboratories, Abbott, Trinity Biotech, Werfen, Protagen, HYCOR Biomedical, HTG Molecular Diagnostics, EUROIMMUN AG
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Diagnosis of Autoimmune Diseases manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Diagnosis of Autoimmune Diseases in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Diagnosis of Autoimmune Diseases in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Diagnosis of Autoimmune Diseases - Market size in 2030?

Ans: The Diagnosis of Autoimmune Diseases - Market size in 2030 will be US$ 1787 million.

Who are the main players in the Diagnosis of Autoimmune Diseases - Market report?

Ans: The main players in the Diagnosis of Autoimmune Diseases - Market are Thermo Fisher Scientific, Siemens, Inova Diagnostics, GRIFOLS, Danaher, Bio-Rad Laboratories, Abbott, Trinity Biotech, Werfen, Protagen, HYCOR Biomedical, HTG Molecular Diagnostics, EUROIMMUN AG

What are the Application segmentation covered in the Diagnosis of Autoimmune Diseases - Market report?

Ans: The Applications covered in the Diagnosis of Autoimmune Diseases - Market report are Rheumatoid Arthritis, Systemic Lupus Erythematosus, Sjögren’s Syndrome, Thyroiditis, Scleroderma, Other

What are the Type segmentation covered in the Diagnosis of Autoimmune Diseases - Market report?

Ans: The Types covered in the Diagnosis of Autoimmune Diseases - Market report are Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test, Other

1 Market Overview
1.1 Diagnosis of Autoimmune Diseases Product Introduction
1.2 Global Diagnosis of Autoimmune Diseases Market Size Forecast
1.3 Diagnosis of Autoimmune Diseases Market Trends & Drivers
1.3.1 Diagnosis of Autoimmune Diseases Industry Trends
1.3.2 Diagnosis of Autoimmune Diseases Market Drivers & Opportunity
1.3.3 Diagnosis of Autoimmune Diseases Market Challenges
1.3.4 Diagnosis of Autoimmune Diseases Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Diagnosis of Autoimmune Diseases Players Revenue Ranking (2023)
2.2 Global Diagnosis of Autoimmune Diseases Revenue by Company (2019-2024)
2.3 Key Companies Diagnosis of Autoimmune Diseases Manufacturing Base Distribution and Headquarters
2.4 Key Companies Diagnosis of Autoimmune Diseases Product Offered
2.5 Key Companies Time to Begin Mass Production of Diagnosis of Autoimmune Diseases
2.6 Diagnosis of Autoimmune Diseases Market Competitive Analysis
2.6.1 Diagnosis of Autoimmune Diseases Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Diagnosis of Autoimmune Diseases Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diagnosis of Autoimmune Diseases as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Routine Laboratory Tests
3.1.2 Inflammatory Markers
3.1.3 Autoantibodies & Immunologic Test
3.1.4 Other
3.2 Global Diagnosis of Autoimmune Diseases Sales Value by Type
3.2.1 Global Diagnosis of Autoimmune Diseases Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Diagnosis of Autoimmune Diseases Sales Value, by Type (2019-2030)
3.2.3 Global Diagnosis of Autoimmune Diseases Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Rheumatoid Arthritis
4.1.2 Systemic Lupus Erythematosus
4.1.3 Sjögren’s Syndrome
4.1.4 Thyroiditis
4.1.5 Scleroderma
4.1.6 Other
4.2 Global Diagnosis of Autoimmune Diseases Sales Value by Application
4.2.1 Global Diagnosis of Autoimmune Diseases Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Diagnosis of Autoimmune Diseases Sales Value, by Application (2019-2030)
4.2.3 Global Diagnosis of Autoimmune Diseases Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Diagnosis of Autoimmune Diseases Sales Value by Region
5.1.1 Global Diagnosis of Autoimmune Diseases Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Diagnosis of Autoimmune Diseases Sales Value by Region (2019-2024)
5.1.3 Global Diagnosis of Autoimmune Diseases Sales Value by Region (2025-2030)
5.1.4 Global Diagnosis of Autoimmune Diseases Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Diagnosis of Autoimmune Diseases Sales Value, 2019-2030
5.2.2 North America Diagnosis of Autoimmune Diseases Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Diagnosis of Autoimmune Diseases Sales Value, 2019-2030
5.3.2 Europe Diagnosis of Autoimmune Diseases Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Diagnosis of Autoimmune Diseases Sales Value, 2019-2030
5.4.2 Asia Pacific Diagnosis of Autoimmune Diseases Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Diagnosis of Autoimmune Diseases Sales Value, 2019-2030
5.5.2 South America Diagnosis of Autoimmune Diseases Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Diagnosis of Autoimmune Diseases Sales Value, 2019-2030
5.6.2 Middle East & Africa Diagnosis of Autoimmune Diseases Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Diagnosis of Autoimmune Diseases Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Diagnosis of Autoimmune Diseases Sales Value
6.3 United States
6.3.1 United States Diagnosis of Autoimmune Diseases Sales Value, 2019-2030
6.3.2 United States Diagnosis of Autoimmune Diseases Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Diagnosis of Autoimmune Diseases Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Diagnosis of Autoimmune Diseases Sales Value, 2019-2030
6.4.2 Europe Diagnosis of Autoimmune Diseases Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Diagnosis of Autoimmune Diseases Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Diagnosis of Autoimmune Diseases Sales Value, 2019-2030
6.5.2 China Diagnosis of Autoimmune Diseases Sales Value by Type (%), 2023 VS 2030
6.5.3 China Diagnosis of Autoimmune Diseases Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Diagnosis of Autoimmune Diseases Sales Value, 2019-2030
6.6.2 Japan Diagnosis of Autoimmune Diseases Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Diagnosis of Autoimmune Diseases Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Diagnosis of Autoimmune Diseases Sales Value, 2019-2030
6.7.2 South Korea Diagnosis of Autoimmune Diseases Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Diagnosis of Autoimmune Diseases Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Diagnosis of Autoimmune Diseases Sales Value, 2019-2030
6.8.2 Southeast Asia Diagnosis of Autoimmune Diseases Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Diagnosis of Autoimmune Diseases Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Diagnosis of Autoimmune Diseases Sales Value, 2019-2030
6.9.2 India Diagnosis of Autoimmune Diseases Sales Value by Type (%), 2023 VS 2030
6.9.3 India Diagnosis of Autoimmune Diseases Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Thermo Fisher Scientific
7.1.1 Thermo Fisher Scientific Profile
7.1.2 Thermo Fisher Scientific Main Business
7.1.3 Thermo Fisher Scientific Diagnosis of Autoimmune Diseases Products, Services and Solutions
7.1.4 Thermo Fisher Scientific Diagnosis of Autoimmune Diseases Revenue (US$ Million) & (2019-2024)
7.1.5 Thermo Fisher Scientific Recent Developments
7.2 Siemens
7.2.1 Siemens Profile
7.2.2 Siemens Main Business
7.2.3 Siemens Diagnosis of Autoimmune Diseases Products, Services and Solutions
7.2.4 Siemens Diagnosis of Autoimmune Diseases Revenue (US$ Million) & (2019-2024)
7.2.5 Siemens Recent Developments
7.3 Inova Diagnostics
7.3.1 Inova Diagnostics Profile
7.3.2 Inova Diagnostics Main Business
7.3.3 Inova Diagnostics Diagnosis of Autoimmune Diseases Products, Services and Solutions
7.3.4 Inova Diagnostics Diagnosis of Autoimmune Diseases Revenue (US$ Million) & (2019-2024)
7.3.5 GRIFOLS Recent Developments
7.4 GRIFOLS
7.4.1 GRIFOLS Profile
7.4.2 GRIFOLS Main Business
7.4.3 GRIFOLS Diagnosis of Autoimmune Diseases Products, Services and Solutions
7.4.4 GRIFOLS Diagnosis of Autoimmune Diseases Revenue (US$ Million) & (2019-2024)
7.4.5 GRIFOLS Recent Developments
7.5 Danaher
7.5.1 Danaher Profile
7.5.2 Danaher Main Business
7.5.3 Danaher Diagnosis of Autoimmune Diseases Products, Services and Solutions
7.5.4 Danaher Diagnosis of Autoimmune Diseases Revenue (US$ Million) & (2019-2024)
7.5.5 Danaher Recent Developments
7.6 Bio-Rad Laboratories
7.6.1 Bio-Rad Laboratories Profile
7.6.2 Bio-Rad Laboratories Main Business
7.6.3 Bio-Rad Laboratories Diagnosis of Autoimmune Diseases Products, Services and Solutions
7.6.4 Bio-Rad Laboratories Diagnosis of Autoimmune Diseases Revenue (US$ Million) & (2019-2024)
7.6.5 Bio-Rad Laboratories Recent Developments
7.7 Abbott
7.7.1 Abbott Profile
7.7.2 Abbott Main Business
7.7.3 Abbott Diagnosis of Autoimmune Diseases Products, Services and Solutions
7.7.4 Abbott Diagnosis of Autoimmune Diseases Revenue (US$ Million) & (2019-2024)
7.7.5 Abbott Recent Developments
7.8 Trinity Biotech
7.8.1 Trinity Biotech Profile
7.8.2 Trinity Biotech Main Business
7.8.3 Trinity Biotech Diagnosis of Autoimmune Diseases Products, Services and Solutions
7.8.4 Trinity Biotech Diagnosis of Autoimmune Diseases Revenue (US$ Million) & (2019-2024)
7.8.5 Trinity Biotech Recent Developments
7.9 Werfen
7.9.1 Werfen Profile
7.9.2 Werfen Main Business
7.9.3 Werfen Diagnosis of Autoimmune Diseases Products, Services and Solutions
7.9.4 Werfen Diagnosis of Autoimmune Diseases Revenue (US$ Million) & (2019-2024)
7.9.5 Werfen Recent Developments
7.10 Protagen
7.10.1 Protagen Profile
7.10.2 Protagen Main Business
7.10.3 Protagen Diagnosis of Autoimmune Diseases Products, Services and Solutions
7.10.4 Protagen Diagnosis of Autoimmune Diseases Revenue (US$ Million) & (2019-2024)
7.10.5 Protagen Recent Developments
7.11 HYCOR Biomedical
7.11.1 HYCOR Biomedical Profile
7.11.2 HYCOR Biomedical Main Business
7.11.3 HYCOR Biomedical Diagnosis of Autoimmune Diseases Products, Services and Solutions
7.11.4 HYCOR Biomedical Diagnosis of Autoimmune Diseases Revenue (US$ Million) & (2019-2024)
7.11.5 HYCOR Biomedical Recent Developments
7.12 HTG Molecular Diagnostics
7.12.1 HTG Molecular Diagnostics Profile
7.12.2 HTG Molecular Diagnostics Main Business
7.12.3 HTG Molecular Diagnostics Diagnosis of Autoimmune Diseases Products, Services and Solutions
7.12.4 HTG Molecular Diagnostics Diagnosis of Autoimmune Diseases Revenue (US$ Million) & (2019-2024)
7.12.5 HTG Molecular Diagnostics Recent Developments
7.13 EUROIMMUN AG
7.13.1 EUROIMMUN AG Profile
7.13.2 EUROIMMUN AG Main Business
7.13.3 EUROIMMUN AG Diagnosis of Autoimmune Diseases Products, Services and Solutions
7.13.4 EUROIMMUN AG Diagnosis of Autoimmune Diseases Revenue (US$ Million) & (2019-2024)
7.13.5 EUROIMMUN AG Recent Developments
8 Industry Chain Analysis
8.1 Diagnosis of Autoimmune Diseases Industrial Chain
8.2 Diagnosis of Autoimmune Diseases Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Diagnosis of Autoimmune Diseases Sales Model
8.5.2 Sales Channel
8.5.3 Diagnosis of Autoimmune Diseases Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Diagnosis of Autoimmune Diseases Market Trends
    Table 2. Diagnosis of Autoimmune Diseases Market Drivers & Opportunity
    Table 3. Diagnosis of Autoimmune Diseases Market Challenges
    Table 4. Diagnosis of Autoimmune Diseases Market Restraints
    Table 5. Global Diagnosis of Autoimmune Diseases Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Diagnosis of Autoimmune Diseases Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Diagnosis of Autoimmune Diseases Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Diagnosis of Autoimmune Diseases Product Type
    Table 9. Key Companies Time to Begin Mass Production of Diagnosis of Autoimmune Diseases
    Table 10. Global Diagnosis of Autoimmune Diseases Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diagnosis of Autoimmune Diseases as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Diagnosis of Autoimmune Diseases Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Diagnosis of Autoimmune Diseases Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Diagnosis of Autoimmune Diseases Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Diagnosis of Autoimmune Diseases Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Diagnosis of Autoimmune Diseases Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Diagnosis of Autoimmune Diseases Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Diagnosis of Autoimmune Diseases Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Diagnosis of Autoimmune Diseases Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Diagnosis of Autoimmune Diseases Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Diagnosis of Autoimmune Diseases Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Diagnosis of Autoimmune Diseases Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Diagnosis of Autoimmune Diseases Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Diagnosis of Autoimmune Diseases Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Diagnosis of Autoimmune Diseases Sales Value by Region (2019-2024) & (%)
    Table 27. Global Diagnosis of Autoimmune Diseases Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Diagnosis of Autoimmune Diseases Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Diagnosis of Autoimmune Diseases Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Diagnosis of Autoimmune Diseases Sales Value, (2025-2030) & (US$ Million)
    Table 31. Thermo Fisher Scientific Basic Information List
    Table 32. Thermo Fisher Scientific Description and Business Overview
    Table 33. Thermo Fisher Scientific Diagnosis of Autoimmune Diseases Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Diagnosis of Autoimmune Diseases Business of Thermo Fisher Scientific (2019-2024)
    Table 35. Thermo Fisher Scientific Recent Developments
    Table 36. Siemens Basic Information List
    Table 37. Siemens Description and Business Overview
    Table 38. Siemens Diagnosis of Autoimmune Diseases Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Diagnosis of Autoimmune Diseases Business of Siemens (2019-2024)
    Table 40. Siemens Recent Developments
    Table 41. Inova Diagnostics Basic Information List
    Table 42. Inova Diagnostics Description and Business Overview
    Table 43. Inova Diagnostics Diagnosis of Autoimmune Diseases Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Diagnosis of Autoimmune Diseases Business of Inova Diagnostics (2019-2024)
    Table 45. Inova Diagnostics Recent Developments
    Table 46. GRIFOLS Basic Information List
    Table 47. GRIFOLS Description and Business Overview
    Table 48. GRIFOLS Diagnosis of Autoimmune Diseases Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Diagnosis of Autoimmune Diseases Business of GRIFOLS (2019-2024)
    Table 50. GRIFOLS Recent Developments
    Table 51. Danaher Basic Information List
    Table 52. Danaher Description and Business Overview
    Table 53. Danaher Diagnosis of Autoimmune Diseases Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Diagnosis of Autoimmune Diseases Business of Danaher (2019-2024)
    Table 55. Danaher Recent Developments
    Table 56. Bio-Rad Laboratories Basic Information List
    Table 57. Bio-Rad Laboratories Description and Business Overview
    Table 58. Bio-Rad Laboratories Diagnosis of Autoimmune Diseases Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Diagnosis of Autoimmune Diseases Business of Bio-Rad Laboratories (2019-2024)
    Table 60. Bio-Rad Laboratories Recent Developments
    Table 61. Abbott Basic Information List
    Table 62. Abbott Description and Business Overview
    Table 63. Abbott Diagnosis of Autoimmune Diseases Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Diagnosis of Autoimmune Diseases Business of Abbott (2019-2024)
    Table 65. Abbott Recent Developments
    Table 66. Trinity Biotech Basic Information List
    Table 67. Trinity Biotech Description and Business Overview
    Table 68. Trinity Biotech Diagnosis of Autoimmune Diseases Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Diagnosis of Autoimmune Diseases Business of Trinity Biotech (2019-2024)
    Table 70. Trinity Biotech Recent Developments
    Table 71. Werfen Basic Information List
    Table 72. Werfen Description and Business Overview
    Table 73. Werfen Diagnosis of Autoimmune Diseases Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Diagnosis of Autoimmune Diseases Business of Werfen (2019-2024)
    Table 75. Werfen Recent Developments
    Table 76. Protagen Basic Information List
    Table 77. Protagen Description and Business Overview
    Table 78. Protagen Diagnosis of Autoimmune Diseases Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Diagnosis of Autoimmune Diseases Business of Protagen (2019-2024)
    Table 80. Protagen Recent Developments
    Table 81. HYCOR Biomedical Basic Information List
    Table 82. HYCOR Biomedical Description and Business Overview
    Table 83. HYCOR Biomedical Diagnosis of Autoimmune Diseases Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Diagnosis of Autoimmune Diseases Business of HYCOR Biomedical (2019-2024)
    Table 85. HYCOR Biomedical Recent Developments
    Table 86. HTG Molecular Diagnostics Basic Information List
    Table 87. HTG Molecular Diagnostics Description and Business Overview
    Table 88. HTG Molecular Diagnostics Diagnosis of Autoimmune Diseases Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Diagnosis of Autoimmune Diseases Business of HTG Molecular Diagnostics (2019-2024)
    Table 90. HTG Molecular Diagnostics Recent Developments
    Table 91. EUROIMMUN AG Basic Information List
    Table 92. EUROIMMUN AG Description and Business Overview
    Table 93. EUROIMMUN AG Diagnosis of Autoimmune Diseases Products, Services and Solutions
    Table 94. Revenue (US$ Million) in Diagnosis of Autoimmune Diseases Business of EUROIMMUN AG (2019-2024)
    Table 95. EUROIMMUN AG Recent Developments
    Table 96. Key Raw Materials Lists
    Table 97. Raw Materials Key Suppliers Lists
    Table 98. Diagnosis of Autoimmune Diseases Downstream Customers
    Table 99. Diagnosis of Autoimmune Diseases Distributors List
    Table 100. Research Programs/Design for This Report
    Table 101. Key Data Information from Secondary Sources
    Table 102. Key Data Information from Primary Sources
    Table 103. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Diagnosis of Autoimmune Diseases Product Picture
    Figure 2. Global Diagnosis of Autoimmune Diseases Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Diagnosis of Autoimmune Diseases Sales Value (2019-2030) & (US$ Million)
    Figure 4. Diagnosis of Autoimmune Diseases Report Years Considered
    Figure 5. Global Diagnosis of Autoimmune Diseases Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Diagnosis of Autoimmune Diseases Revenue in 2023
    Figure 7. Diagnosis of Autoimmune Diseases Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Routine Laboratory Tests Picture
    Figure 9. Inflammatory Markers Picture
    Figure 10. Autoantibodies & Immunologic Test Picture
    Figure 11. Other Picture
    Figure 12. Global Diagnosis of Autoimmune Diseases Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 13. Global Diagnosis of Autoimmune Diseases Sales Value Market Share by Type, 2023 & 2030
    Figure 14. Product Picture of Rheumatoid Arthritis
    Figure 15. Product Picture of Systemic Lupus Erythematosus
    Figure 16. Product Picture of Sjögren’s Syndrome
    Figure 17. Product Picture of Thyroiditis
    Figure 18. Product Picture of Scleroderma
    Figure 19. Product Picture of Other
    Figure 20. Global Diagnosis of Autoimmune Diseases Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 21. Global Diagnosis of Autoimmune Diseases Sales Value Market Share by Application, 2023 & 2030
    Figure 22. North America Diagnosis of Autoimmune Diseases Sales Value (2019-2030) & (US$ Million)
    Figure 23. North America Diagnosis of Autoimmune Diseases Sales Value by Country (%), 2023 VS 2030
    Figure 24. Europe Diagnosis of Autoimmune Diseases Sales Value (2019-2030) & (US$ Million)
    Figure 25. Europe Diagnosis of Autoimmune Diseases Sales Value by Country (%), 2023 VS 2030
    Figure 26. Asia Pacific Diagnosis of Autoimmune Diseases Sales Value (2019-2030) & (US$ Million)
    Figure 27. Asia Pacific Diagnosis of Autoimmune Diseases Sales Value by Country (%), 2023 VS 2030
    Figure 28. South America Diagnosis of Autoimmune Diseases Sales Value (2019-2030) & (US$ Million)
    Figure 29. South America Diagnosis of Autoimmune Diseases Sales Value by Country (%), 2023 VS 2030
    Figure 30. Middle East & Africa Diagnosis of Autoimmune Diseases Sales Value (2019-2030) & (US$ Million)
    Figure 31. Middle East & Africa Diagnosis of Autoimmune Diseases Sales Value by Country (%), 2023 VS 2030
    Figure 32. Key Countries/Regions Diagnosis of Autoimmune Diseases Sales Value (%), (2019-2030)
    Figure 33. United States Diagnosis of Autoimmune Diseases Sales Value, (2019-2030) & (US$ Million)
    Figure 34. United States Diagnosis of Autoimmune Diseases Sales Value by Type (%), 2023 VS 2030
    Figure 35. United States Diagnosis of Autoimmune Diseases Sales Value by Application (%), 2023 VS 2030
    Figure 36. Europe Diagnosis of Autoimmune Diseases Sales Value, (2019-2030) & (US$ Million)
    Figure 37. Europe Diagnosis of Autoimmune Diseases Sales Value by Type (%), 2023 VS 2030
    Figure 38. Europe Diagnosis of Autoimmune Diseases Sales Value by Application (%), 2023 VS 2030
    Figure 39. China Diagnosis of Autoimmune Diseases Sales Value, (2019-2030) & (US$ Million)
    Figure 40. China Diagnosis of Autoimmune Diseases Sales Value by Type (%), 2023 VS 2030
    Figure 41. China Diagnosis of Autoimmune Diseases Sales Value by Application (%), 2023 VS 2030
    Figure 42. Japan Diagnosis of Autoimmune Diseases Sales Value, (2019-2030) & (US$ Million)
    Figure 43. Japan Diagnosis of Autoimmune Diseases Sales Value by Type (%), 2023 VS 2030
    Figure 44. Japan Diagnosis of Autoimmune Diseases Sales Value by Application (%), 2023 VS 2030
    Figure 45. South Korea Diagnosis of Autoimmune Diseases Sales Value, (2019-2030) & (US$ Million)
    Figure 46. South Korea Diagnosis of Autoimmune Diseases Sales Value by Type (%), 2023 VS 2030
    Figure 47. South Korea Diagnosis of Autoimmune Diseases Sales Value by Application (%), 2023 VS 2030
    Figure 48. Southeast Asia Diagnosis of Autoimmune Diseases Sales Value, (2019-2030) & (US$ Million)
    Figure 49. Southeast Asia Diagnosis of Autoimmune Diseases Sales Value by Type (%), 2023 VS 2030
    Figure 50. Southeast Asia Diagnosis of Autoimmune Diseases Sales Value by Application (%), 2023 VS 2030
    Figure 51. India Diagnosis of Autoimmune Diseases Sales Value, (2019-2030) & (US$ Million)
    Figure 52. India Diagnosis of Autoimmune Diseases Sales Value by Type (%), 2023 VS 2030
    Figure 53. India Diagnosis of Autoimmune Diseases Sales Value by Application (%), 2023 VS 2030
    Figure 54. Diagnosis of Autoimmune Diseases Industrial Chain
    Figure 55. Diagnosis of Autoimmune Diseases Manufacturing Cost Structure
    Figure 56. Channels of Distribution (Direct Sales, and Distribution)
    Figure 57. Bottom-up and Top-down Approaches for This Report
    Figure 58. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Clotting Factors Ⅷ Market Insights, Forecast to 2030

120 Pages
Type: Report
Code: QYRE-Auto-21S8513
Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Rare Genetic Disease Diagnosis Solution - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-17L15214
Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Endoscopes for Otology - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-19V14797
Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Immunotherapy Drugs for Neuroblastoma - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-39R14639
Thu Dec 12 00:00:00 UTC 2024

Add to Cart